Small Molecule SIRT1 Modulators Using Structure-Based Drug Design for the Treatment of Cancer and Metabolic Diseases
Received Date: Jun 01, 2023 / Published Date: Jul 28, 2023
Abstract
Exacerbations, which regularly lead to emergency branch visits and hospitalizations, are the most important drivers of morbidity and utilization of fitness care sources amongst sufferers with continual obstructive pulmonary disorder (COPD). Appropriate preference of an effective, long-term pharmacotherapy for decreasing exacerbations is key to COPD management. In this review, we summarize the handy long-acting, upkeep pharmacotherapeutic choices for sufferers with reasonable or extreme COPD and talk about realistic concerns in the administration of these patients. Membrane transporters modify the trafficking of endogenous and exogenous molecules throughout organic obstacles and inside the neurovascular unit. In annoying talent harm (TBI), they average the dynamic motion of therapeutic pills and harm mediators amongst neurons, endothelial cells and glial cells, thereby turning into vital determinants of pathogenesis and nice pharmacotherapy after TBI.
Citation: Mendeleev D (2023) Small Molecule SIRT1 Modulators Using Structure-Based Drug Design for the Treatment of Cancer and Metabolic Diseases. J CellMol Pharmacol 7: 163. Doi: 10.4172/jcmp.1000163
Copyright: © 2023 Mendeleev D. This is an open-access article distributed underthe terms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.
Share This Article
Recommended Journals
黑料网 Journals
Article Tools
Article Usage
- Total views: 382
- [From(publication date): 0-2023 - Nov 25, 2024]
- Breakdown by view type
- HTML page views: 316
- PDF downloads: 66